Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06320613
Other study ID # KYLL20240117-2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 20, 2024
Est. completion date September 20, 2024

Study information

Verified date March 2024
Source Weifang Medical University
Contact Lin Cheng, B.S
Phone 17667404256
Email 1318216353@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to investigate the effect of implementing snap-needle therapy combined with ginger paste during anesthesia recovery on the recovery of gastrointestinal function after gynecological laparoscopy.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date September 20, 2024
Est. primary completion date September 20, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. ASA I or II; 2. Performing gynecologic laparoscopic procedures under general anesthesia; Exclusion Criteria: 1. Age = 18 or =65; 2. The patient has a previous history of PONV, digestive disorders, etc; 3. Ulcers, infections, and skin tears at acupressure and acupuncture (snap-needle) treatment sites; 4. Patients allergic to ginger; 5. Inability to follow protocol or refusal to participant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Acupuncture therapy
After disinfecting (alcohol or 0.9% Normal saline) the skin at the acupuncture point, use small tweezers to clip the handle of the needle, remove the adhesive tape and stab the acupuncture point at a perpendicular angle, and then press the thumb with moderate pressure on the snap-needle embedded needle site in order for the patient to feel localized soreness and distension as appropriate. The snap-needle was removed after 24 hours, and the pressing time point remained unchanged.
Ginger Acupuncture Point Patch
Ginger was thinly sliced and then cut into 2-3cm diameter ginger discs according to a circular mold and covered with a sterile circular dressing. The ginger compress was removed within 6 hours.

Locations

Country Name City State
China Lin Cheng Weifang Shandong

Sponsors (2)

Lead Sponsor Collaborator
Weifang Medical University Weifang People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative nausea and vomiting The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade =I means that the symptom occurs. The severity and incidence of PONV at 0.5 hours postoperatively. Measured at 0.5 hours postoperatively.
Primary Postoperative nausea and vomiting The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade =I means that the symptom occurs. The severity and incidence of PONV at 1 hours postoperatively. Measured at 1 hours postoperatively.
Primary Postoperative nausea and vomiting The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade =I means that the symptom occurs. The severity and incidence of PONV at 3 hours postoperatively. Measured at 3 hours postoperatively.
Primary Postoperative nausea and vomiting The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade =I means that the symptom occurs. The severity and incidence of PONV at 6 hours postoperatively. Measured at 6 hours postoperatively.
Primary Postoperative nausea and vomiting The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade =I means that the symptom occurs. The severity and incidence of PONV at 12 hours postoperatively. Measured at 12 hours postoperatively.
Primary Postoperative nausea and vomiting The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade =I means that the symptom occurs. The severity and incidence of PONV at 24 hours postoperatively. Measured at 24 hours postoperatively.
Primary Abdominal distention The severity and incidence of Abdominal distention at 0.5 hours postoperatively. Measured at 0.5 hours postoperatively.
Primary Abdominal distention The severity and incidence of Abdominal distention at 1 hours postoperatively. Measured at 1 hours postoperatively.
Primary Abdominal distention The severity and incidence of Abdominal distention at 3 hours postoperatively. Measured at 3 hours postoperatively.
Primary Abdominal distention The severity and incidence of Abdominal distention at 6 hours postoperatively. Measured at 6 hours postoperatively.
Primary Abdominal distention The severity and incidence of Abdominal distention at 12 hours postoperatively. Measured at 12 hours postoperatively.
Primary Abdominal distention The severity and incidence of Abdominal distention at 24 hours postoperatively. Measured at 24 hours postoperatively.
Primary Time to first flatus Record the time of the first flatus. The earlier the time of first flatus, the earlier the time of recovery of gastrointestinal function. Approximately 24 hours after surgery.
Secondary Postoperative pain response The Visual Analog Score was used to assess pain response at 0.5 hours postoperatively.
The score ranges from 0 (pain free or no pain) to 10 (worst pain).
Measured at 0.5 hours postoperatively.
Secondary Postoperative pain response The Visual Analog Score was used to assess pain response at 1 hours postoperatively.
The score ranges from 0 (pain free or no pain) to 10 (worst pain).
Measured at 1 hours postoperatively.
Secondary Postoperative pain response The Visual Analog Score was used to assess pain response at 3 hours postoperatively.
The score ranges from 0 (pain free or no pain) to 10 (worst pain).
Measured at 3 hours postoperatively.
Secondary Postoperative pain response The Visual Analog Score was used to assess pain response at 6 hours postoperatively.
The score ranges from 0 (pain free or no pain) to 10 (worst pain).
Measured at 6 hours postoperatively.
Secondary Postoperative pain response The Visual Analog Score was used to assess pain response at 12 hours postoperatively.
The score ranges from 0 (pain free or no pain) to 10 (worst pain).
Measured at 12 hours postoperatively.
Secondary Postoperative pain response The Visual Analog Score was used to assess pain response at 24 hours postoperatively.
The score ranges from 0 (pain free or no pain) to 10 (worst pain).
Measured at 24 hours postoperatively.
Secondary Consumption of postoperative analgesic Record the type and dosage of postoperative analgesic within 24 hours after surgery. Approximately 24 hours after surgery.
Secondary Consumption of postoperative rescue antiemetic Record the type and dosage of postoperative rescue antiemetic within 24 hours after surgery. Approximately 24 hours after surgery
Secondary Time to first defecation Record the time of first defecation. Approximately 24 hours after surgery.
See also
  Status Clinical Trial Phase
Completed NCT04466046 - The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
Completed NCT03139383 - Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery N/A
Recruiting NCT04069806 - Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section N/A
Completed NCT04043247 - Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting N/A
Terminated NCT01975727 - Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting Phase 2
Completed NCT03662672 - Rib Raising for Post-operative Ileus N/A
Completed NCT00090155 - 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) Phase 3
Recruiting NCT05375721 - Prevention of PONV With Traditional Chinese Medicine N/A
Completed NCT02480088 - Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism Phase 4
Recruiting NCT06137027 - Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting Early Phase 1
Not yet recruiting NCT05529004 - A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy Phase 2
Completed NCT02944942 - Risk Factors for Postoperative Nausea/Vomiting N/A
Recruiting NCT02571153 - Low Doses of Ketamine and Postoperative Quality of Recovery Phase 4
Completed NCT02550795 - Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer N/A
Completed NCT02449291 - Study of APD421 as PONV Treatment (no Prior Prophylaxis) Phase 3
Recruiting NCT01442012 - Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery N/A
Completed NCT01478165 - Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting N/A
Unknown status NCT01268748 - Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain N/A
Completed NCT02143531 - Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting Phase 4
Completed NCT00734929 - Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy Phase 4